CVA Family Office’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.77K Buy
+19
New +$1.68K ﹤0.01% 1554
2025
Q2
Sell
-9
Closed -$447 1283
2025
Q1
$447 Buy
+9
New +$569 ﹤0.01% 1338

Other funds holding ACLS

CVA Family Office's ACLS Position: Q1 2026 in Review

CVA Family Office opened a new position in Axcelis (ACLS) in Q1 2026: 19 shares worth $1.77K. The stake represents ﹤0.01% of the portfolio and ranks #1554 among its holdings. This is a return to the name: CVA Family Office previously reported a position in ACLS as recently as Q1 2025.

CVA Family Office first reported a position in ACLS in Q1 2025 and has held it in 2 quarters since. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • CVA Family Office held 19 shares of Axcelis worth $1.77K as of Q1 2026.
  • Axcelis was a new CVA Family Office position in Q1 2026.
  • Axcelis made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #1554 holding.
  • CVA Family Office first reported a position in Axcelis in Q1 2025 and has held it in 2 quarters since.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.